Skip to content

Author

Huai-Min Liu

We have 3 of 39 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

G Protein‐Coupled Receptor 68 Promotes the Progression of Triple‐Negative Breast Cancer and Cuproptosis Resistance via the MEK/ERK Signaling Pathway

Cuproptosis is a type of cell death that depends on the energy production process inside cells, and it is important in cancer treatment. This study aimed to identify cuproptosis‐associated genes in triple‐negative breast cancer (TNBC) and reveal regulatory pathways. We applied weighted gene co‐expression network analys...

Jia Wang, Shi-Lei Gao, Li-Han Zhang et al. · 0 citations
Open access Oct 2026

Comparative effectiveness of neoadjuvant treatment strategies and predictors of pathological complete response in locally advanced esophageal squamous cell carcinoma: a real-world retrospective cohort study

Objective To compare pathological complete response (pCR) across different neoadjuvant treatment strategies in patients with locally advanced esophageal squamous cell carcinoma (ESCC) and to identify clinicopathological factors associated with pCR. Methods In this single-center retrospective cohort study, 247 consecuti...

Xiao-Li Yuan, Yu-Ying Liang, T. Han et al. · 0 citations
Review Open access Aug 2026

Immunosuppressive cells as barriers to cancer therapy: mechanisms and emerging solutions

This review offers a comprehensive framework for understanding and surmounting immunosuppressive barriers in cancer therapy and develops systematic synergistic strategies such as multi-pathway checkpoint blockade, ADC-immunotherapy combinations, temporally and spatially optimized conventional therapies, and targeted ag...

Meng-Meng Liu, Yi-Chen Zhu, He-Miao Liang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.